Prospective, multicenter study to evaluate performance and safety of a re-engineered temporary lead for InterStim™ therapy evaluation.
Elterman D, Michaels J, Margolis E, Harris-Hicks J, Burgess K, Betts C, Harding C, Towers G, Hashim H, Ojo-Carons A, White A, Cannon-Smith T, Grunow N, Bittner K, Xavier K.
Elterman D, et al. Among authors: xavier k.
Neurourol Urodyn. 2022 Nov;41(8):1731-1738. doi: 10.1002/nau.24987. Epub 2022 Jul 28.
Neurourol Urodyn. 2022.
PMID: 35900298